Basheer Isah Waziri

Dr. Basheer Isah Waziri

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026
Verified
Journal Article
Open access
PDF file
AAAhmad Abdulhadi
Ahmad Abdulhadi
NANasiru Abdullahi
Nasiru Abdullahi
IYIbrahim Yusuf
Ibrahim Yusuf
BWBasheer Isah Waziri
Basheer Isah Waziri
KMKasimu Mamuda
Kasimu Mamuda
HSHamisu M. Salihu
Hamisu M. Salihu
Background and Objective: Tuberculosis (TB) has continued to be one of the global threats, affecting millions of individuals globally, including the maternal and child health (MCH) populations and individuals with HIV/AIDS. TB infected 10.8 million individuals, leading to 1.25 million deaths across the globe annually, leaving 4 million missing cases contributing to the global TB burden. This study aims to unveil innovative approaches to TB diagnosis, challenges, and the future direction of this field. Methods: A comprehensive literature search was conducted to retrieve studies published between 2019 and 2024 from PubMed, Google Scholar, and Web of Science. The studies were reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and screened using the Rayyan tool. The quality and risk of bias of the included studies were assessed using Quality Assessment of Diagnostic Accuracy Studies 2 for diagnostic accuracy studies and Strengthening the Reporting of Observational Studies in Epidemiology for observational studies. A random effects model was employed to calculate the pooled sensitivity and specificity, while Egger’s test and funnel plots were utilized to evaluate publication bias. R and MetaDTA software were used for all the statistical analyses. Results: The review included 25 studies with sample sizes ranging from 100 to 6,520 participants and assessed various innovative approaches for diagnosing TB, including molecular methods, biomarker-based techniques, and artificial intelligence (AI) applications. The most common approach was molecular testing, specifically cartridge-based tests. The overall sensitivity of these methods was 0.79 (95% confidence interval [CI]: 0.70–0.86), with a heterogeneity index (I²) of 92.9% and a p < 0.0001. The specificity was recorded at 0.93 (95% CI: 0.87–0.96), with an I² of 94.8% and a p < 0.0001. Conclusion and Global Health Implications: This review reinforces the promise of innovative diagnostic methods, especially cartridge-based molecular tests, for improving TB detection. However, moderate sensitivity and high heterogeneity emphasize the need for cautious implementation and further validation of new tools such as the AI-based and biomarker-based. Strategic investment in research and contextual deployment is critical for closing the TB diagnosis gap globally.

6 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HAHalima Ibrahim Ahmed
Halima Ibrahim Ahmed
BWBasheer Isah Waziri
Basheer Isah Waziri
HMHassan A. Murtala
Hassan A. Murtala
NANasiru Abdullahi
Nasiru Abdullahi
IYIbrahim Yusuf
Ibrahim Yusuf
HSHamisu M. Salihu
Hamisu M. Salihu
Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with an increased risk of stroke and heart failure, with both genetic and environmental factors contributing to its pathophysiology. Emerging evidence suggests that KCNH2 gene dysregulation may play a role in arrhythmogenesis, yet data in African populations remain limited. This study investigated KCNH2 gene expression in AF patients and its association with clinical and laboratory parameters. In a matched case–control design at Aminu Kano Teaching Hospital, Nigeria, 25 participants (14 AF patients and 11 age-matched controls) were enrolled. Peripheral blood was collected for RNA extraction and lipid profiling. KCNH2 expression was quantified using reverse transcription real-time PCR, and relative fold changes were calculated via the 2^−ΔΔCt method. Compared with controls, AF patients exhibited significantly higher total cholesterol, LDL cholesterol, and triglyceride levels (p ≤ 0.029). KCNH2 expression was markedly reduced in AF patients, with a 17-fold decrease (median 0.12, IQR 0.04–0.71) versus controls (2.06, IQR 1.30–2.85; p < 0.001). QTc intervals were significantly prolonged in AF patients, and serum triglycerides were negatively correlated with KCNH2 expression (r = –0.472, p = 0.003). These findings suggest that downregulation of KCNH2, in combination with lipid abnormalities and QTc prolongation, may contribute to AF pathogenesis, highlighting the potential utility of molecular and metabolic profiling in risk assessment and precision management of AF.

1 January 2026 in African Journal of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
HIHusna F. Ibrahim
Husna F. Ibrahim
NANasiru Abdullahi
Nasiru Abdullahi
IYIbrahim Yusuf
Ibrahim Yusuf
BWBasheer Isah Waziri
Basheer Isah Waziri
AAAhmad Abdulhadi
Ahmad Abdulhadi
HSHamisu M. Salihu
Hamisu M. Salihu
Background: Antimicrobial resistance (AMR) is a major global public health threat. ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) pose a major threat owing to resistance to last-line antibiotics. Genomic surveillance is crucial to understanding global and regional antimicrobial resistance genes (ARGs) in AMR transmission. Aim: This systematic review synthesised global genomic evidence to identify global and region-specific ARGs distribution among ESKAPE pathogens. Methods: Following PRISMA guidelines, studies published January 2019 to December 2024 were identified from PubMed, Google Scholar, and Web of Science. Eligible studies reported genomic characteristics and resistance patterns of one or more ESKAPE pathogens from any source. Results: Seventy-seven studies were included, with most originating from Asia, followed by Europe and Africa. Clinical isolates predominated K. pneumoniae was the most frequently investigated pathogen, followed by S. aureus, P. aeruginosa, and A. baumannii. The most reported resistance genes were blaCTX-M, blaNDM, and blaSHV. Distinct regional patterns of antimicrobial resistance gene (ARG) distribution were observed, with tetracycline and quinolone resistance genes prevailing in Africa and South America, and blaOXA variants dominating in Asia and Europe. Region-specific ARG patterns were identified through descriptive synthesis and comparative analysis of study-reported frequencies. Conclusion: This review provides a synthesised global map of ARG distribution in ESKAPE pathogens, highlighting surveillance gaps in underrepresented regions and non-clinical settings. Addressing these gaps will support targeted genomic surveillance and stewardship programmes. What this study adds: This study contributes to the body of knowledge by mapping global and regional antimicrobial resistance gene patterns in ESKAPE pathogens, identifying key surveillance gaps and informing targeted AMR monitoring and stewardship strategies.